mannitol has been researched along with ginsenosides in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, T; Wang, Z; Wei, L | 1 |
| Hu, M; Li, J; Li, L; Luan, X; Wang, K; Xu, H; Ye, F; Yu, X; Zhang, D | 1 |
| Gu, Y; Jiang, C; Ren, K; Wang, L; Yao, Q | 1 |
3 other study(ies) available for mannitol and ginsenosides
| Article | Year |
|---|---|
[Formulation optimization of panax notoginsenoside orally fast disintegration tablets].
Topics: Cellulose; Chemistry, Pharmaceutical; Drugs, Chinese Herbal; Ginsenosides; Lactose; Mannitol; Tablets; Tensile Strength | 2008 |
Influence of type and proportion of lyoprotectants on lyophilized ginsenoside Rg3 liposomes.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; beta-Cyclodextrins; Cell Line, Tumor; Freeze Drying; Ginsenosides; Glucose; Humans; Inositol; Lactose; Liposomes; Mannitol; Particle Size; Phospholipids; Polyethylene Glycols; Protective Agents; Sucrose; Trehalose; X-Ray Diffraction | 2016 |
Rg1 in combination with mannitol protects neurons against glutamate-induced ER stress via the PERK-eIF2 α-ATF4 signaling pathway.
Topics: Activating Transcription Factor 4; Animals; Apoptosis; Central Nervous System Agents; Diuretics, Osmotic; Drug Therapy, Combination; eIF-2 Kinase; Endoplasmic Reticulum Stress; Eukaryotic Initiation Factor-2; Ginsenosides; Glutamic Acid; Male; Mannitol; Neurons; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2020 |